The FDA has recently granted clearance for the portable AiRTouch X-ray device developed by Aspenstate to be used for humans. This small, handheld device joins the array of telehealth products being developed recently. This device is paired with a touchscreen for an intuitive interface, and it can upload images directly to clinical storage systems, without requiring a separate computer.
Portable devices such as these are easier to disinfect than their relatively immobile predecessors, making them advantageous in the ongoing pandemic. The streamlined process of conducting x-rays using this device helps save time for healthcare providers, helping to combat the shortage of staff many facilities are currently facing. Additionally, the portability of this device allows x-rays to be conducted without requiring patients to be moved to other areas of the hospital. This works to aid patient comfort, as well as limit the spread of COVID-19 throughout the facilities.
The AiRTouch’s innovative portability also lends itself to uses outside of hospital settings, that other x-ray systems may not be capable of. This includes environments such as ambulances, sports medicine, and veterinary settings.
David Lee, Vice President and COO of Aspenstate, emphasized the device’s effectiveness, stating that “Clients have noticed a dramatic increase in capacity and the ability to move patients through quickly and efficiently. They find that the device is very simple to use, and the integrated software and portable features allow them to work outside of the limitations of traditional X-ray solutions.”
The telehealth monitoring market has grown tremendously in recent years, fueled by increasing awareness of the benefits of remote monitoring and home healthcare. Growth was heavily driven by telehealth monitoring for disease management, which represented approximately more than half of the total telehealth market value in 2018.
Currently, the U.S. boasts the most mature telehealth market in the world, as well as a diverse competitive landscape, attributable to a trend towards reimbursement reform and successes of large-scale deployment initiatives. Moreover, the Veteran’s Health Administration (VHA), America’s largest purveyor of home telehealth, continues to rapidly expand the size of its remote patient monitoring (RPM) programs and funding.
In 2018, the total market for telehealth monitoring valued at approximately $1.1 billion, a 12.6% increase over 2017, and is expected to grow at a CAGR of 11.4% by 2025.
To read more on the telehealth market, refer to iData Research’s report page: Telemedicine Market Analysis, Size, Trends | Global | 2019-2025 | MedCore
COVID-19 has already caused significant social and economic impacts on medical device organizations world-wide. At iData Research, it is our prime responsibility to keep you updated on the latest market trends in the industry. We have created a dedicated page, COVID-19: Implications for the Medical Device Industry, to post news updates and provide information on the current market situation. It is our intention that this page can help industry leaders ask the right questions, and shed light on what the future might hold for medical device markets.
Stryker Emergency Authorization for Respirator Decontamination Stryker Emergency Authorization for Respirator Decontamination